Contributions of upper gut hormones and motility to the energy intake-suppressant effects of intraduodenal nutrients in healthy, lean men - a pooled-data analysis.

作者: Gudrun Schober , Kylie Lange , Robert E. Steinert , Amy T. Hutchison , Natalie D. Luscombe-Marsh

DOI: 10.14814/PHY2.12943

关键词:

摘要: We have previously identified pyloric pressures and plasma cholecystokinin (CCK) concentrations as independent determinants of energy intake following administration intraduodenal lipid intravenous CCK. evaluated in healthy men whether these parameters also determine response to protein, whether, across the nutrients, any predominant gastrointestinal (GI) factors exist, or many make small contributions. Data from nine published studies, which antropyloroduodenal pressures, GI hormones, /appetite perceptions were measured during protein infusions, pooled. In all studies was quantified immediately after infusions. Specific variables for inclusion a mixed-effects multivariable model determination predictors chosen assessment collinearity, within-subject correlations between determined using bivariate analyses adjusted repeated measures. models based on there significant effects amplitude antral pressure waves, premeal glucagon-like peptide-1 (GLP-1) time-to-peak GLP-1 concentrations, AUC bloating scores (P < 0.05), trends basal (BPP), duodenal peak CCK hunger nausea (0.05 P ≤ 0.094), be subsequent intake. including only BPP an determinant 0.05). No single parameter models, relatively small. Taken together, while mechanisms contribute regulation acute by their contribution latter is much less. Moreover, are likely reflect small, cumulative contributions range interrelated factors.

参考文章(61)
Matthias Tschöp, David L. Smiley, Mark L. Heiman, Ghrelin induces adiposity in rodents. Nature. ,vol. 407, pp. 908- 913 ,(2000) , 10.1038/35038090
N. Geary, H. R. Kissileff, F. X. Pi-Sunyer, V. Hinton, Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 262, ,(1992) , 10.1152/AJPREGU.1992.262.6.R975
R. Heddle, J. Dent, J. Toouli, N. W. Read, Topography and measurement of pyloric pressure waves and tone in humans American Journal of Physiology-gastrointestinal and Liver Physiology. ,vol. 255, ,(1988) , 10.1152/AJPGI.1988.255.4.G490
A. Santangelo, M. Peracchi, D. Conte, M. Fraquelli, M. Porrini, Physical state of meal affects gastric emptying, cholecystokinin release and satiety. British Journal of Nutrition. ,vol. 80, pp. 521- 527 ,(1998) , 10.1017/S0007114598001615
R. Heddle, J. Dent, N. W. Read, L. A. Houghton, J. Toouli, M. Horowitz, G. J. Maddern, J. Downton, Antropyloroduodenal motor responses to intraduodenal lipid infusion in healthy volunteers. American Journal of Physiology-gastrointestinal and Liver Physiology. ,vol. 254, ,(1988) , 10.1152/AJPGI.1988.254.5.G671
Barbara A. Parker, Selena Doran, Judith Wishart, Michael Horowitz, Ian M. Chapman, Effects of small intestinal and gastric glucose administration on the suppression of plasma ghrelin concentrations in healthy older men and women. Clinical Endocrinology. ,vol. 62, pp. 539- 546 ,(2005) , 10.1111/J.1365-2265.2005.02254.X
Julie Berg Schmidt, Nikolaj Ture Gregersen, Sue D. Pedersen, Johanne L. Arentoft, Christian Ritz, Thue W. Schwartz, Jens Juul Holst, Arne Astrup, Anders Sjödin, Effects of PYY3–36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men American Journal of Physiology-endocrinology and Metabolism. ,vol. 306, ,(2014) , 10.1152/AJPENDO.00569.2013
Rachel L. Batterham, Helen Heffron, Saloni Kapoor, Joanna E. Chivers, Keval Chandarana, Herbert Herzog, Carel W. Le Roux, E. Louise Thomas, Jimmy D. Bell, Dominic J. Withers, Critical role for peptide YY in protein-mediated satiation and body-weight regulation Cell Metabolism. ,vol. 4, pp. 223- 233 ,(2006) , 10.1016/J.CMET.2006.08.001
M. Horowitz, T. Vilsbøll, M. Zdravkovic, M. Hammer, S. Madsbad, Patient‐reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once‐daily human GLP‐1 analogue, liraglutide Diabetes, Obesity and Metabolism. ,vol. 10, pp. 593- 596 ,(2008) , 10.1111/J.1463-1326.2008.00861.X